POTENTIAL OF A NOVEL ANTI-PLATELET APTAMER IN OPTIMIZING ANTITHROMBOTIC
新型抗血小板适体在优化抗血栓药物方面的潜力
基本信息
- 批准号:9061785
- 负责人:
- 金额:$ 24.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAnimal ModelAnticoagulant therapyAnticoagulantsAnticoagulationAntidotesBlood PlateletsBlood VesselsCardiopulmonary BypassCardiovascular systemCellsClinicalClinical TrialsCoagulantsCoagulation ProcessCutaneousDeep Vein ThrombosisDiseaseEnvironmentFunctional disorderGenerationsGoalsHealedHealthcareHemorrhageHemostatic AgentsHemostatic functionHeparinHospitalizationImpaired wound healingIn VitroInflammationInflammation MediatorsInflammatoryInflammatory ResponseInterventionMeasuresModelingMonitorOperative Surgical ProceduresOutcomePlatelet ActivationProceduresProductionPulmonary EmbolismQuality of lifeRattusResourcesRiskSafetyStimulusSurfaceTechnologyTestingTherapeuticTherapeutic InterventionThrombinThrombosisTimeTranslationsTraumaWorkWound Healingacute coronary syndromeangiogenesisaptamerbasecerebrovascularclinical practiceclinically relevantcritical periodexhaustionhealingimprovedimproved outcomein vivoinnovationnovelnovel therapeuticspreventprogramssynergismvon Willebrand Factor
项目摘要
Profound and controllable anticoagulation is essential during a large number of clinical procedures including percutaneous and surgical revascularization procedures (PCI and CABG), aortic surgery and other vascular interventions. Immediate anticoagulation therapy is also required in a variety of thrombotic diseases such as acute coronary syndromes, pulmonary embolism or deep vein thrombosis. Significant risks and side effects of all of these interventions and therapies include profound bleeding or thrombosis leading to cerebrovascular or cardiovascular compromise. The clinical and financial implications of these outcomes can be profound and are associated with prolonged hospitalization, reduced quality of life, and increased health-care resource
utilization. The proposed work extends the basic discoveries of novel therapeutic anticoagulant aptamer/antidote pairs. We believe that a crucial next step in the translation of these agents to clinical practice is the testing in predictive in vitro and animal models such as those we will employ in this project. The proposed work will reveal whether this innovative therapeutic strategy can provide superior anticoagulation in prothrombotic environments, while avoiding undesired effects such as bleeding, platelet dysfunction, systemic inflammation and impaired wound healing.
在大量临床手术中,包括经皮和外科血运重建手术(PCI和CABG)、主动脉手术和其他血管介入手术,深度可控的抗凝治疗至关重要。急性冠脉综合征、肺栓塞或深静脉血栓形成等多种血栓性疾病也需要立即抗凝治疗。所有这些干预和治疗的显著风险和副作用包括导致脑血管或心血管损害的严重出血或血栓形成。这些结果的临床和财务影响可能是深远的,并与住院时间延长,生活质量下降和卫生保健资源增加有关
利用率拟议的工作扩展了新的治疗性抗凝剂适体/解毒剂对的基本发现。我们认为,将这些药物转化为临床实践的关键下一步是在预测性体外和动物模型中进行测试,例如我们将在本项目中使用的模型。拟议的工作将揭示这种创新的治疗策略是否可以在促血栓形成环境中提供上级抗凝作用,同时避免不良反应,如出血,血小板功能障碍,全身炎症和伤口愈合受损。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard Clinton Becker其他文献
Richard Clinton Becker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard Clinton Becker', 18)}}的其他基金
DEVELOPING A TRANSLATABLE PLATFORM FOR REVERSIBLE PLATELET INHIBITION
开发可逆血小板抑制的可翻译平台
- 批准号:
8469091 - 财政年份:2013
- 资助金额:
$ 24.92万 - 项目类别:
DTMI-Center for Thrombotic and Hemostatic Disorders
DTMI-血栓和止血疾病中心
- 批准号:
8250552 - 财政年份:2012
- 资助金额:
$ 24.92万 - 项目类别:
DTMI-Center for Thrombotic and Hemostatic Disorders
DTMI-血栓和止血疾病中心
- 批准号:
8469084 - 财政年份:2012
- 资助金额:
$ 24.92万 - 项目类别:
DTMI-Center for Thrombotic and Hemostatic Disorders
DTMI-血栓和止血疾病中心
- 批准号:
8656777 - 财政年份:2012
- 资助金额:
$ 24.92万 - 项目类别:
DTMI-Center for Thrombotic and Hemostatic Disorders
DTMI-血栓和止血疾病中心
- 批准号:
8840627 - 财政年份:2012
- 资助金额:
$ 24.92万 - 项目类别:
Translational Research Skills Development Core (TRSDC): Training Future Generati
转化研究技能发展核心(TRSDC):培训未来一代
- 批准号:
8469095 - 财政年份:
- 资助金额:
$ 24.92万 - 项目类别:
Translational Research Skills Development Core (TRSDC): Training Future Generati
转化研究技能发展核心(TRSDC):培训未来一代
- 批准号:
8656790 - 财政年份:
- 资助金额:
$ 24.92万 - 项目类别:
LABORATORY ASSESSMENT OF TARGETED ANTITHROMBOTIC THERAPIES
靶向抗血栓治疗的实验室评估
- 批准号:
8391973 - 财政年份:
- 资助金额:
$ 24.92万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 24.92万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 24.92万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 24.92万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 24.92万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 24.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 24.92万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 24.92万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 24.92万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 24.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 24.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists